ATE126509T1 - Disäuren von diarylstyrylchinolin. - Google Patents
Disäuren von diarylstyrylchinolin.Info
- Publication number
- ATE126509T1 ATE126509T1 AT90305640T AT90305640T ATE126509T1 AT E126509 T1 ATE126509 T1 AT E126509T1 AT 90305640 T AT90305640 T AT 90305640T AT 90305640 T AT90305640 T AT 90305640T AT E126509 T1 ATE126509 T1 AT E126509T1
- Authority
- AT
- Austria
- Prior art keywords
- disacids
- diarylstyrylchinoline
- compounds
- leukotriene
- asthmatic
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003199 leukotriene receptor blocking agent Substances 0.000 abstract 2
- 230000003266 anti-allergic effect Effects 0.000 abstract 1
- 230000001088 anti-asthma Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 239000000924 antiasthmatic agent Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000001120 cytoprotective effect Effects 0.000 abstract 1
- 150000002617 leukotrienes Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Quinoline Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
- Detergent Compositions (AREA)
- Ink Jet Recording Methods And Recording Media Thereof (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35647889A | 1989-05-24 | 1989-05-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE126509T1 true ATE126509T1 (de) | 1995-09-15 |
Family
ID=23401598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90305640T ATE126509T1 (de) | 1989-05-24 | 1990-05-23 | Disäuren von diarylstyrylchinolin. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0399818B1 (de) |
| JP (1) | JPH07103107B2 (de) |
| KR (1) | KR900018035A (de) |
| AT (1) | ATE126509T1 (de) |
| AU (1) | AU5581190A (de) |
| CA (1) | CA2017376C (de) |
| DE (1) | DE69021639T2 (de) |
| FI (1) | FI902555A7 (de) |
| IL (1) | IL94484A0 (de) |
| NO (1) | NO902301L (de) |
| NZ (1) | NZ233752A (de) |
| PT (1) | PT94129A (de) |
| ZA (1) | ZA903983B (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3927930A1 (de) * | 1989-08-24 | 1991-02-28 | Bayer Ag | Cyclisch substituierte (chinolin-2-yl-methoxy)phenyl-essig-saeure-derivate |
| EP0480716A1 (de) | 1990-10-12 | 1992-04-15 | Merck Frosst Canada Inc. | Gesättigte Hydroxyalkylchinolinsäuren zur Verwendung als Leukotrien-Antagonisten |
| DK0480717T3 (da) * | 1990-10-12 | 1999-02-08 | Merck Frosst Canada Inc | Umættede hydroxyalkylquinolinsyrer som leukotrienantagonister |
| US5266568A (en) * | 1990-10-12 | 1993-11-30 | Merck Frosst Canada, Inc. | Hydroxyalkylquinoline ether acids as leukotriene antagonists |
| US5856322A (en) * | 1990-10-12 | 1999-01-05 | Merck Frosst Canada, Inc. | Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
| IL99683A0 (en) * | 1990-10-12 | 1992-08-18 | Merck Frosst Canada Inc | Hydroxy alkylquinoline ether acids and pharmaceutical compositions containing them |
| IE920499A1 (en) * | 1991-02-21 | 1992-08-26 | Merck Frosst Canada Inc | Quinoline-containing ketoacids as leukotriene antagonists |
| EP0575494A1 (de) * | 1991-03-13 | 1993-12-29 | Smithkline Beecham Corporation | Leukotrienantogonisten |
| US5149703A (en) * | 1991-09-06 | 1992-09-22 | Merck Frosst Canada, Inc. | Quinoline-substituted chromans and related compounds as leukotriene antagonists |
| US5270324A (en) * | 1992-04-10 | 1993-12-14 | Merck Frosst Canada, Inc. | Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists |
| IL109431A (en) * | 1993-05-14 | 2001-01-11 | Warner Lambert Co | Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds |
| US5491172A (en) * | 1993-05-14 | 1996-02-13 | Warner-Lambert Company | N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
| US5438141A (en) * | 1993-05-21 | 1995-08-01 | Merck Frosst Canada, Inc. | Heteroaryl and haloaryl quinoline derivatives of cyclopropaneacetic acid as leukotriene antagonists |
| ES2080656B1 (es) * | 1993-07-19 | 1996-10-16 | Merck Frosst Canada Inc | Acidos de hidroxialquilquinolina fluorados como antagonistas del leucotrieno. |
| US5750539A (en) * | 1995-06-07 | 1998-05-12 | Merck Frosst Canada | Heteroaryl diol acids as leukotriene antagonists |
| US5668150A (en) * | 1996-07-26 | 1997-09-16 | Abbott Laboratories | Non-symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis |
| US6310211B1 (en) | 1996-09-10 | 2001-10-30 | Pharmacia & Upjohn Company | 8-hydroxy-7-substituted quinolines as anti-viral agents |
| US5783586A (en) * | 1996-10-01 | 1998-07-21 | Abbott Laboratories | Heteroarylmethoxyphenylthioalkyl carboxylates as inhibitors of leukotriene biosynthesis |
| SG91339A1 (en) | 2000-03-08 | 2002-09-17 | Givaudan Sa | Organoleptic compositions |
| US6492396B2 (en) * | 2000-05-16 | 2002-12-10 | Cephalon, Inc. | Substituted thioacetamides |
| US20050009812A1 (en) * | 2001-10-05 | 2005-01-13 | Takuya Seko | Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| WO2007022946A1 (de) | 2005-08-21 | 2007-03-01 | Abbott Gmbh & Co. Kg | Heterocyclische verbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren |
| JP6038914B2 (ja) * | 2011-07-26 | 2016-12-07 | スン プハルマ アドバンセド リサーチ カンパニー リミテド | キノリン−、キノキサリン、又はベンゾチアゾールベースのシステイニルロイコトリエンアンタゴニスト（ｌｔｃ４） |
| CA2903746C (en) | 2013-03-08 | 2022-08-23 | Amy Hauck Newman | Potent and selective inhibitors of monoamine transporters; method of making; and use thereof |
| BR112016013018A2 (pt) * | 2013-12-09 | 2017-08-08 | Ucb Biopharma Sprl | Derivados heteroaromáticos bicíclicos fundidos como moduladores de atividade de tnf |
| US11365195B2 (en) | 2017-11-13 | 2022-06-21 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Atypical inhibitors of monoamine transporters; method of making; and use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO174506B (no) * | 1984-10-30 | 1994-02-07 | Usv Pharma Corp | Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser |
| US4732978A (en) * | 1985-10-03 | 1988-03-22 | American Home Products Corporation | Novel substituted naphthyloxymethyl quinoline derivatives as anti-inflammatory and antiallergy agents |
| IE59889B1 (en) * | 1986-02-14 | 1994-04-20 | Merck Frosst Canada Inc | 2-substituted quinoline dioic acids |
| EP0271287A3 (de) * | 1986-12-11 | 1990-06-13 | Merck Frosst Canada Inc. | Chinolindicarbonsäuren und ihre Amide |
| IL88433A0 (en) * | 1987-11-25 | 1989-06-30 | Merck Frosst Canada Inc | Diarylstyrylquinoline diacids and pharmaceutical compositions containing them |
-
1990
- 1990-05-21 NZ NZ233752A patent/NZ233752A/xx unknown
- 1990-05-23 AU AU55811/90A patent/AU5581190A/en not_active Abandoned
- 1990-05-23 CA CA002017376A patent/CA2017376C/en not_active Expired - Fee Related
- 1990-05-23 ZA ZA903983A patent/ZA903983B/xx unknown
- 1990-05-23 NO NO90902301A patent/NO902301L/no unknown
- 1990-05-23 FI FI902555A patent/FI902555A7/fi not_active IP Right Cessation
- 1990-05-23 AT AT90305640T patent/ATE126509T1/de not_active IP Right Cessation
- 1990-05-23 DE DE69021639T patent/DE69021639T2/de not_active Expired - Fee Related
- 1990-05-23 EP EP90305640A patent/EP0399818B1/de not_active Expired - Lifetime
- 1990-05-23 IL IL94484A patent/IL94484A0/xx unknown
- 1990-05-23 PT PT94129A patent/PT94129A/pt not_active Application Discontinuation
- 1990-05-24 KR KR1019900007608A patent/KR900018035A/ko not_active Withdrawn
- 1990-05-24 JP JP2132754A patent/JPH07103107B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| NO902301D0 (no) | 1990-05-23 |
| ZA903983B (en) | 1991-03-27 |
| FI902555A0 (fi) | 1990-05-23 |
| CA2017376C (en) | 2000-07-18 |
| IL94484A0 (en) | 1991-03-10 |
| JPH07103107B2 (ja) | 1995-11-08 |
| NZ233752A (en) | 1993-05-26 |
| PT94129A (pt) | 1991-02-08 |
| DE69021639T2 (de) | 1996-02-15 |
| EP0399818B1 (de) | 1995-08-16 |
| CA2017376A1 (en) | 1990-11-24 |
| KR900018035A (ko) | 1990-12-20 |
| NO902301L (no) | 1990-11-26 |
| FI902555A7 (fi) | 1990-11-25 |
| JPH0372459A (ja) | 1991-03-27 |
| AU5581190A (en) | 1990-12-13 |
| EP0399818A1 (de) | 1990-11-28 |
| DE69021639D1 (de) | 1995-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE126509T1 (de) | Disäuren von diarylstyrylchinolin. | |
| FI903331A0 (fi) | Substituerade kinazolinoner, vilka aer anvaendbara som angiotensin-ii-antagonister. | |
| DK0480717T3 (da) | Umættede hydroxyalkylquinolinsyrer som leukotrienantagonister | |
| PT778277E (pt) | Derivados heterociclicos substituidos como antagonistas do crf | |
| NO943792D0 (no) | Kinolinderivater som leukotrienantagonister | |
| DK0486948T3 (da) | Forbindelser, der hæmmer retrovirale proteaser | |
| ATE6422T1 (de) | 3-aryloxy-3-phenylpropylamine. | |
| ATE119774T1 (de) | Imidazopyridinderivate und ihre verwendung. | |
| ES2087456T3 (es) | (biciclo-hetero-arilmetoxi)indoles como inhibidores de la biosintesis de leucotrienos. | |
| DK506587A (da) | Imidderivater | |
| EP0318084A3 (de) | Benzoheterazole | |
| NO995963D0 (no) | Karboksamider anvendelige som 5-HTIF-agonister | |
| DK0404440T3 (da) | Substituerede sulfonamider og beslægtede forbindelser til behandling af astma, arthritis og beslægtede sygdomme | |
| GB9302046D0 (en) | Antiumoral compound-v | |
| FI914795A0 (fi) | Hydroxialkylkinolinetersyror som leukotrienantagonister. | |
| DE3678622D1 (de) | Leukotrienantagonisten. | |
| FI901277A0 (fi) | 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ. | |
| EP0318085A3 (de) | Heterazoldialkansäure | |
| DK0381114T3 (da) | Exo-3,4-O-benzyliden-3"-demethylchartreusin og salte deraf | |
| ATE141918T1 (de) | Isoquinolinderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |